Please wait a minute...
Search Asian J Urol Advanced Search
Share 
Asian Journal of Urology, 2024, 11(3): 373-376    doi: 10.1016/j.ajur.2023.09.001
  本期目录 | 过刊浏览 | 高级检索 |
Role of buccal mucosa graft ureteroplasty in the surgical management of pyeloplasty failure
Matthew Leea*(),Elizabeth Nagodaa,David Straussa,Matthew Loechera,Michael Stifelmanb,Lee Zhaoc
aDepartment of Urology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA
bDepartment of Urology, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA
cDepartment of Urology, New York University Grossman School of Medicine, New York University Langone Health System, New York, NY, USA
下载:  HTML  PDF (1032KB) 
输出:  BibTeX | EndNote (RIS)      
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
Abstract: 

Objective: Secondary pyeloplasty for recurrent ureteropelvic junction obstructions may be a safe and feasible surgical option for patients. This study aimed to demonstrate outcomes of utilizing a non-transecting buccal mucosa graft ureteroplasty for management of recurrent ureteropelvic junction obstruction after prior failed pyeloplasty.

Methods: We performed a retrospective review of our Collaborative of Reconstructive Robotic Ureteral Surgery database for all consecutive patients who underwent buccal mucosa graft ureteroplasty between April 2012 and June 2022 for management of recurrent ureteropelvic junction obstructions after prior failed pyeloplasty. The primary outcome included surgical success which was defined as the absence of flank pain and no obstruction on imaging.

Results: Overall, ten patients were included in our analysis. The median stricture length was 2.5 (interquartile range [IQR] 1.8-4.0) cm. The median operative time was 230.5 (IQR 199.5-287.0) min and median estimated blood loss was 50.0 (IQR 28.8-102.5) mL. At a median follow-up of 10.3 (IQR 6.2-14.8) months, 80% of patients were surgically successful and there were no major (Clavien-Dindo Grade>2) complications.

Conclusion: Buccal mucosa graft ureteroplasty is a valuable non-transecting surgical option for patients with recurrent ureteropelvic junction obstructions who failed prior pyeloplasty and has comparable outcomes to the literature regarding standard transecting techniques.

Key words:  Ureteral obstruction    Buccal mucosa graft    Pyeloplasty    Robotic    Stricture
收稿日期:  2023-07-03           接受日期:  2023-09-28      出版日期:  2024-07-20      发布日期:  2024-08-13      整期出版日期:  2024-07-20
引用本文:    
. [J]. Asian Journal of Urology, 2024, 11(3): 373-376.
Matthew Lee, Elizabeth Nagoda, David Strauss, Matthew Loecher, Michael Stifelman, Lee Zhao. Role of buccal mucosa graft ureteroplasty in the surgical management of pyeloplasty failure. Asian Journal of Urology, 2024, 11(3): 373-376.
链接本文:  
http://www.ajurology.com/CN/10.1016/j.ajur.2023.09.001  或          http://www.ajurology.com/CN/Y2024/V11/I3/373
  
Variable Value
Age, year 39.5 (29.5-52.5)
Body mass index, kg/m2 25.7 (24.3-30.7)
Sex
Male 5 (50)
Female 5 (50)
Etiology of stricture
Congenital 4 (40)
Iatrogenic 6 (60)
Laterality
Left 8 (80)
Right 2 (20)
  
Variable Patient (n=10) Value
#1 #2 #3 #4 #5 #6 #7 #8 #9 #10
Length of stricture, cm 2 2 4 3 7 4 1 1 3 2 2.5 (1.8-4.0)a
Operative time, min 146 201 265 225 280 236 308 206 195 318 230.5 (199.5-287.0)a
Estimated blood loss, mL 150 60 30 50 25 25 100 50 110 50 50.0 (28.8-102.5)a
Intraoperative complication No No No No No No No No No No 0%
Indocyanine green usage Yes Yes Yes Yes Yes Yes No No No No 60%
Length of stay, day 1 1 0 0 1 1 0 0 1 1 1 (0-1)a
Follow-up, month 22.4 47.1 11.4 11.6 9.2 12.3 8.5 6.0 6.3 6.0 10.3 (6.2-14.8)a
Major (Clavien-Dindo Grade>2) complication No No No No No No No No No No 0%
Surgical success Yes Yes No Yes No Yes Yes Yes Yes Yes 80%
  
[1] Sundaram C, Hopf H, Bahler C. Long-term outcomes of robotassisted laparoscopic pyeloplasty for ureteropelvic junction obstruction. Urology 2016; 90:106-11.
[2] Etafy M, Pick D, Said S, Hsueh T, Kerbl D, Mucksavage P, et al. Robotic pyeloplasty: the University of California-Irvine experience. J Urol 2011; 185:2196-200.
[3] Gupta N, Nayyar R, Hemal A, Mukherjee S, Kumar R, Dogra P. Outcome analysis of robotic pyeloplasty: a large single-centre experience. BJUI 2010; 105:980-3.
[4] Lee M, Lee Z, Strauss D, Jun MS, Koster H, Asghar A, et al. Multi-institutional experience comparing outcomes of adult patients undergoing secondary versus primary robotic pyeloplasty. Urology 2020; 145:275-80.
[5] Zhao LC, Weinberg AC, Lee Z, Ferretti MJ, Koo HP, Metro MJ, et al. Robotic ureteral reconstruction using buccal mucosa grafts: a multi-institutional experience. Eur Urol 2018; 73:419-26.
[6] Lee Z, Lee M, Koster H, Lee R, Cheng N, Jun M, et al. A multiinstitutional experience with robotic ureteroplasty with buccal mucosa graft: an updated analysis of intermediateterm outcomes. Urology 2021; 147:306-10.
[7] Lee Z, Moore B, Giusto L, Eun D. Use of indocyanine green during robot-assisted ureteral reconstructions. Eur Urol 2015; 67:291-8.
[8] Atug F, Burgess SV, Castle E, Thomas J. Role of robotics in the management of secondary ureteropelvic junction obstruction. Int J Clin Pract 2006; 60:9-11.
[9] Sundaram CP, Grubb R, Rehman J, Nan Y, Chen C, Landman J, et al. Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction. J Urol 2003; 169:2037-40.
[10] Hammady A, Elbadry MS, Rashed E, Moussa A, Gamal W, Dawood W, et al. Laparoscopic repyeloplasty after failed open repair of ureteropelvic junction obstruction: a casematched multi-institutional study. Scand J Urol 2017; 51:402-6.
No related articles found!
[1] Brian W. Chao, Daniel D. Eun. Robotic reconstructive surgery: The time has arrived[J]. Asian Journal of Urology, 2024, 11(3): 339 -340 .
[2] Dong Hao,Peng Yonghan,Li Ling,Gao Xiaofeng. Prevention strategies for ureteral stricture following ureteroscopic lithotripsy[J]. Asian Journal of Urology, 2018, 5(2): 94 -100 .
[3] Rongfu Liu, Xiangcheng Qin, Chengyong Ji, Weixin Zeng, Yufeng Yang, Wei Tan. Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo[J]. Asian Journal of Urology, 2015, 2(3): 151 -157 .
[4] Antonio B. Porcaro, Nicolò de Luyk, Paolo Corsi, Marco Sebben, Alessandro Tafuri, Davide Inverardi, Davide De Marchi, Irene Tamanini, Matteo Brunelli, Maria Angela Cerruto, Gian Luca Salvagno, Gian Cesare Guidi, Walter Artibani. Robotic assisted radical prostatectomy accelerates postoperative stress recovery: Final results of a contemporary prospective study assessing pathophysiology of cortisol peri-operative kinetics in prostate cancer surgery[J]. Asian Journal of Urology, 2016, 3(2): 88 -95 .
[5] Ponco Birowo,Nur Rasyid,Chaidir A. Mochtar,Bambang S. Noegroho,H.R. Danarto,Besut Daryanto,Lukman Hakim,Dyandra Parikesit,Fakhri Rahman,S. Cahyo Ariwicaksono. Daily activities and training experiences of urology residents during the coronavirus disease 2019 pandemic in Indonesia: A nationwide survey[J]. Asian Journal of Urology, 2023, 10(2): 119 -127 .
[6] Giovanni Saredi,Giacomo Maria Pirola,Francesca Ambrosini,Simone Barbieri,Lorenzo Berti,Andrea Pacchetti,Domenico Iovino,Giuseppe Ietto,Letizia Libassi,Giulio Carcano. Feasibility of en bloc thulium laser enucleation of the prostate in a large case series. Are results enhanced by experience?[J]. Asian Journal of Urology, 2019, 6(4): 339 -345 .
[7] Kuangzheng Liu,Xinglin Chen,Xiaohan Ren,Yuqing Wu,Shancheng Ren,Chao Qin. SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy[J]. Asian Journal of Urology, 2021, 8(3): 303 -314 .
[8] Nora Naqos,Wafaa Kaikani. Prostate cancer—highlights from American Society of Clinical Oncology virtual meeting 2020[J]. Asian Journal of Urology, 2022, 9(3): 282 -286 .
[9] Eric Chung. A review of regenerative therapies as penile rehabilitation in men following primary prostate cancer treatment: Evidence for erectile restoration and cavernous nerve regeneration[J]. Asian Journal of Urology, 2022, 9(3): 287 -293 .
[10] Biagio Barone,Luigi De Luca,Luigi Napolitano,Vincenzo Francesco Caputo,Mariano Marsicano,Gennaro Cancelmo,Massimiliano Creta,Ferdinando Fusco. Bilateral calcified Macroplastique® after 12 years[J]. Asian Journal of Urology, 2022, 9(3): 334 -336 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed